rss
Br J Ophthalmol 90:1060-1066 doi:10.1136/bjo.2006.097436
  • Perspective

Light and inherited retinal degeneration

Table 1

 Effects of light exposure on animal models of retinal degeneration

Gene product (symbol) Mutation Species Findings* Human counterpart†
ADRP, autosomal dominant retinitis pigmentosa; ARRP, autosomal recessive retinitis pigmentosa; DR, dark rearing; LCA, Leber congenital amaurosis; NCL, neuronal ceroid lipofuscinosis; PPCA, pigmented paravenous chorioretinal atrophy; RP12, retinitis pigmentosa type 12; RPCEV, retinitis pigmentosa with Coats-like exudative vasculopathy; tg, transgenic; vLINCL, Turkish variant late infantile neuronal ceroid lipofuscinosis.
*“Protection” does not necessarily imply complete rescue. Light exposure protocols vary among studies, but “exacerbation by light” refers to accelerated degeneration in light brighter than that used for routine animal housing in a given study. Because sufficiently bright light can cause retinal damage in wild type animals,6 only cases in which exacerbation of degeneration significantly exceeds the damage produced in wild type controls by the same light regimen are included.
†Except where noted, the listed human diseases arise from mutations in genes orthologous to those mutated in the respective animal models. Phenotypes may not correspond precisely. Where more than one human disease is listed, these represent alternative phenotypes arising from mutations in the same gene.
‡These phenotypes are associated with mutations in the human gene TULP1 (Tubby-like protein 1), which is related to mouse Tub, but not orthologous.
§Ser334ter transgenic rats exhibit dominant retinal degeneration, but this mutation has not been reported in human RP.
Modified by light
Arrestin (Sag) Knockout8 Mouse Protection by DR9 Oguchi disease,11 ARRP12
Exacerbation by light9,10
ATP/GTP binding protein 1 (Agtpbp1, Nna1) Putative regulatory mutation (pcd1J)13 Mouse Exacerbation by light14 Unknown
Crumbs homologue 1 (Crb1) Knockout15 Mouse Exacerbation by light15 LCA, RP12, RPCEV,16 PPCA17
Mertk (Mertk) Deletion18 Rat Protection by DR19–21 ARRP24
Exacerbation by light21–23
Rds/peripherin (Rds) Insertion25 Mouse No protection by DR26Exacerbation by light26 Several forms of retinal dystrophy27
Rhodopsin (RHO) Thr4Arg (T4R)28 Dog Exacerbation by light29 ADRP30,31
Rhodopsin (Rho) Val20Gly, Pro23His, Pro27Leu (VPP)32 Mouse (tg) Protection by DR33 Exacerbation by light34 ADRP35
Rhodopsin (Rho) Pro23His (P23H)36,37 Rat (tg) Protection by DR38 Exacerbation by light38–42 ADRP35
Rhodopsin kinase (Grk1, Rhok) Knockout43 Mouse Protection by DR43 Exacerbation by light10,43 Oguchi disease44
Rim protein (Abca4, Abcr) Knockout45 Mouse Prevention of A2E accumulation by DR46 Stargardt disease and other retinal dystrophies47
RPE65 (Rpe65) Knockout48 Mouse Protection by DR49 Resistance to light damage50 LCA, early onset severe retinal dystrophy51
Solute carrier family 6, taurine transporter (Slc6a6, Taut) Knockout52 Mouse Protection by DR53 Unknown
Tubby (Tub) Splice donor site mutation54,55 Mouse Protection by DR56 ARRP,57,58 LCA59
Unknown Nervous mutation (nr)60 Mouse No protection by DR61 Exacerbation by light14 Unknown
Not modified by light
Ceroid lipofuscinosis, neuronal 8 (Cln8) Frameshift62 Mouse No protection by DR63 NCL-8,62 vLINCL64
Microphthalmia associated transcription factor (Mitf) Asp222Asn (D222N)65 Mouse No protection by DR66 Waardenburg syndrome type II,67 Tietz syndrome68
Rhodopsin (Rho) Lys296Glu (K296E)69 Mouse (tg) No protection by DR69 ADRP70
Rhodopsin (Rho) Ser334ter71 Rat (tg) No protection by DR38,72 ADRP§
No exacerbation by light in most experiments38,41,73
Rhodopsin (Rho) Knockout74 Mouse Resistance to light damage50 ARRP75

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.